JPRN-UMIN000041098已完成未知
Efficacy and Safety of FOLFOXIRI plus Bevacizumab and Doublet plus Biologics in Patients With Previously Untreated BRAF V600E-mutant Metastatic Colorectal Cancer: A Multi-institutional retrospective study (WJOG13219G) - A Multi-institutional retrospective study for Patients With Previously Untreated BRAF V600E-mutant Metastatic Colorectal Cancer (WJOG13219G)
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) patients with another concomitant cancer at the time of diagnosis
研究者
相似试验
已完成
2 期
Safety and efficacy of FOLFOX plus bevacizumab or FOLFIRI plus bevacizumab as second line Therapy in Advanced colorectal Cancer previously treated with bevacizumab.JPRN-UMIN000002378Japan South West Oncology Group45
已完成
2 期
Phase II trial of FOLFOXIRI + Bevacizumab in patients with untreated metastatic colorectal cancerPatients with metastatic colorectal cancerJPRN-UMIN000017102Translational Research Informatics Center, Foundation for Biomedical Research and Innovation45
进行中（未招募）
不适用
Phase III study to compare two different chemotherapy treatments to determine whether the first line with the three drugs + bevacizumab followed by a second line with the same regimen may provide better results than treatment with two drugs + bevacizumab is the first and the second treatment lineEUCTR2014-004436-19-ITG.O.N.O.
进行中（未招募）
不适用
Clinical trial to evaluate the efficacy of 5FU/LV, Oxaliplatin, Irinotecan (FOLFOXIRI chemotherapy regimen) and Bevacizumab prior and after surgery compared to 5FU/LV, Oxaliplatin (FOLFOX chemotherapy regimen) after surgery of resectable colorectal liver metastases.EUCTR2010-023575-25-DEniversität Regensburg
招募中
2 期
A phase II trial of FOLFOXIRI+Bevacizumab as preoperative chemotherapy for locally advanced lower rectal cancerower rectal cancerJPRN-UMIN000031028Kobe University Graduate School of Medicine40